FTRE (Fortrea) יחס מחיר להכנסות חזויות

סמל ולוגו של המותג Fortrea Clinical (FTRE)

Is it worth investing in a business that relies on attracting top-tier experts in the CRO sector? The forward P/S multiple provides the answer, and the value of 0.70 shows the current magnitude of this metric for Fortrea Holdings Inc. (FTRE). Alliances with IT centers to accelerate drug development support the growth in market capitalization. Simultaneously, Fortrea Holdings Inc. (FTRE) is modernizing its laboratories, ensuring full capacity utilization without downtime.

FTRE Fortrea Holdings Inc: מחיר עתידי (Forward) למכירות בטווח 12.03.2024 - 17.11.2026

פילוחי מדדים מקיפים ואנליטיקה עבור Fortrea Holdings Inc. (FTRE)

- מחיר נוכחי ושווי מניות חזוי:
- מדדי הערכת שווי שוק של העסק:
ניתוח ראשוני של החברה:Fortrea Holdings Inc FTRE
מוצר מקורי של Fortrea Clinical

Fortrea Holdings Inc. is facing a degradation of pricing power due to a contraction in biotech funding and forced discounting of services. The forward P/S ratio assesses market capitalization relative to expected annual revenue. By analyzing the projected P/S level, an investor can determine the ratio of the asset's current value to future cash flows from sales. This metric allows for the timely identification of an overvalued security against a backdrop of a real slowdown in revenue growth rates.